Scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in primates that rapidly detects faces. The findings help not only explain how primates sense and recognize faces, but could also have implications for understanding conditions such as autism, where face detection and recognition are often impaired from early childhood.
A new study in mice hints at the promise of an eventual alternative treatment option for the “wet” version of age-related macular degeneration (AMD).
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announced today the appointment of Karen Petrou as Board Chair, effective July 1, 2024. Petrou succeeds David Brint, who is retiring after eight years of dedicated service.
Ahead of Independence Day on July 4, Virginia Tech experts can speak on a variety of topics, including fireworks safety, economic lessons from eating contests, grilling safety tips, and more. To schedule an interview, please contact the media relations office at [email protected]. Fireworks safety The July 4th holiday brings a dramatic increase in eye injuries each year.
A specialist with Bascom Palmer Eye Institute explains the importance of tears for both physical and emotional health.
TGF has expanded its Grant-in-Aid Program, broadening its focus and increasing funding. Three new grants have just been funded under the new guidelines.
Indiana University School of Medicine’s Yoshikazu Imanishi, PhD, was recently awarded a four-year, $2.1 million grant from the National Eye Institute and a three-year, $500,000 grant from the Foundation Fighting Blindness to study genetic causes of blindness.
Washington University School of Medicine in St. Louis led a clinical trial that tests the safety and efficacy of an FDA-approved drug in stabilizing vision in patients with RVCL-S, a rare genetic disease that affects tiny blood vessels in the body.
The discovery of how intricate networks of blood vessels in the eye and brain are formed could inspire new treatments for glaucoma, diabetic retinopathy, and stroke.
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.
Glaucoma Research Foundation, the nation’s most experienced nonprofit foundation dedicated solely to curing glaucoma and restoring vision through innovative research, recently elected David S. Friedman, MD, PhD, MPH to its Board of Directors.
Two prominent ophthalmologists join the TGF Board.
The U.S. Food and Administration (FDA) last week qualified the American Academy of Ophthalmology’s patient-reported outcome measure for premium intraocular lenses (IOLs) as a Medical Device Development Tool (MDDT).
This month, SriniVas R. Sadda, MD, FARVO, was welcomed as the new 2024 – 2025 president for the Association for Research in Vision and Ophthalmology (ARVO) at its Annual Meeting held recently in Seattle, Wash.
In what they believe is a solution to a 30-year biological mystery, neuroscientists at Johns Hopkins Medicine say they have used genetically engineered mice to address how one mutation in the gene for the light-sensing protein rhodopsin results in congenital stationary night blindness.
The American Macular Degeneration Foundation supports a diverse portfolio of research investigations to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD.
Judy and Charles Munnerlyn, PhD, were honored to recognize their extraordinary contributions to improving vision for people around the world.
The Truhlsen-Marmor Museum of the Eye® today announced the opening of Hoodwinked: 19th Century Quack Medicine.
Fu-Shin Yu, Ph.D., professor of ophthalmology, visual and anatomical sciences in the Wayne State University School of Medicine, received an award from the National Eye Institute of the National Institutes of Health for his study aiming to reverse the adverse effects of diabetes on eyesight.
Research to Prevent Blindness is pleased to announce that it has opened a new round of grant funding for high-impact vision research, including research related to glaucoma, age-related macular degeneration, inherited retinal diseases, myopia, amblyopia, low vision and many more.
A new approach to gene therapy resets cell homeostasis. Clinical trials to treat the retinal disorders Retinitis Pigmentosa, Stargardt's, and Geographic Atrophy (late dry macular degeneration) are underway and showing promise.
New study led by Univ. of Leicester & Cooper Medical School of Rowan Univ. finds early patching improves treatment for childhood 'lazy eye' (amblyopia). Published in Lancet. Optimizing care for young patients.
Healthy sight allows us to see all of the world’s wonders, and healthy retinas make healthy sight possible. When retinal disease strikes and a clear view of the world is replaced by a curtain-like shadow, central blurriness, or straight lines that appear wavy, it’s critical to seek out the expert care uniquely provided by a retina specialist.
Regener-Eyes® LLC, a leading name in the ophthalmic industry, is registered, regulated, inspected and in full compliance with all FDA regulations. Regener-Eyes® is dedicated to safety, quality, and compliance.
The prestigious group brings together key industry leaders and members of the corporate community dedicated to glaucoma patient care.
The American Society of Retina Specialists (ASRS) invites members of the press to cover the latest advances in retina science and practice during its 42nd Annual Scientific Meeting July 17-20, 2024.
An eye movement study led by a New York Institute of Technology psychology researcher suggests that techniques used in a Baroque-era painting could help today’s marketers catch the attention of modern consumers.
As people prepare to thrill at the phenomenon of the eclipse today, Lauren Lusardi, OD, FAAO, an optometrist with Atlantic Health System in New Jersey, breaks down how the event makes us susceptible to eye damage and useful tips on how to protect yourself.
The April 8 solar eclipse—a spectacular show in the sky when the moon will pass in front of the sun—is almost here. University of Miami ophthalmologists explain how to view it safely.
The Wilmer Eye Institute, Johns Hopkins Medicine has received two awards totaling more than $20 million from the National Eye Institute at the National Institutes of Health, both of which will be used for a six-year clinical trial investigating a potential treatment for the most common inherited retinal disease, retinitis pigmentosa.
Staring at the sun can damage your eyes in less than a minute. An ophthalmologist explains how to protect your vision during the 2024 eclipse.
It’s a celestial anomaly that happens only once in a blue moon. A Penn State Health expert talks about the safest ways for you to witness the solar eclipse on Monday, April 8.
Findings from a National Eye Institute-supported study show for the first time that when babies look at photos of unfamiliar everyday scenes, such as an office or a lab, they tend to fixate on the same regions where adults find meaning. This inclination to home in on what’s interesting or meaningful grows more pronounced as babies age. The findings, published in Infancy, provide a more nuanced understanding of visual development, which may lead to earlier detection of brain-based causes of vision problems, such as cerebral/cortical visual impairment.
National Eye Institute researchers studying human retinas discovered 87 target genes where a mix of environmental factors likely influence one’s risk of developing age-related macular degeneration (AMD), a leading cause of vision loss in people ages 65 and older.
Researchers have used advanced sequencing technology to determine how the mix of microbes present in patients with healthy eyes differs from the mix found in patients with dry eye.
Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
On Monday, April 8, much of the United States will have the opportunity to witness a partial or total eclipse.
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
The free glaucoma audiobook, narrated by Bianca Beach, is available for patients and their families to listen, download, and share.
Warning follows Mount Sinai’s landmark eye damage case linked to the 2017 eclipse
On April 8, 2024, 40 million people across the United States, Canada, and Mexico will have the opportunity to experience a true celestial spectacle, a rare total solar eclipse as the moon passes between the sun and the Earth, blocking daylight for several minutes.
Millions face vision loss from AMD, yet access to crucial services, assistive devices, and care remain a hurdle. AMDF declares the 4th week of February Access in Sight! AMD Advocacy and Action Week (Feb 25th-29th) to mobilize efforts and demand change for the macular degeneration and low vision community. #AccessinSight
Research shows this tool can strongly support clinicians for patient care
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
